Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.27M | -6.90M | -6.85M | -6.85M | -6.74M |
| Total Depreciation and Amortization | 180.40K | 168.40K | 170.70K | 159.40K | 181.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 45.60K | 44.50K | 42.90K | 36.90K | 5.80K |
| Change in Net Operating Assets | 1.14M | 232.60K | 581.40K | 604.50K | -296.90K |
| Cash from Operations | -5.90M | -6.46M | -6.05M | -6.05M | -6.84M |
| Capital Expenditure | -335.50K | -192.70K | -173.70K | -1.10K | -1.30K |
| Sale of Property, Plant, and Equipment | 3.70K | 3.70K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -331.80K | -189.00K | -173.70K | -1.10K | -1.30K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -4.20K | -4.10K | -4.00K | -4.00K | -151.40K |
| Issuance of Common Stock | 13.13M | 8.47M | 8.35M | 3.85M | 3.85M |
| Repurchase of Common Stock | -- | -- | -- | -400.00 | -400.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.73M | -1.25M | -1.25M | -464.70K | -464.70K |
| Cash from Financing | 11.39M | 7.22M | 7.09M | 3.38M | 3.23M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.16M | 568.40K | 863.00K | -2.67M | -3.62M |